Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.0015
-0.0012 (-44.44%)
Inactive · Last trade price on May 18, 2026
STO:LPGO Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
908.90K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 10.29M | -6.12M | -37.30% |
| Dec 31, 2023 | 16.41M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 2.21M | -1.80M | -44.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Lipigon Pharmaceuticals AB News
- 5 months ago - Lipigon Pharmaceuticals AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Lipigon Pharmaceuticals AB Annual report: Q4 2025 - Filings
- 9 months ago - Lipigon Pharmaceuticals AB Press release: Study Result - Filings
- 10 months ago - Lipigon Pharmaceuticals AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Lipigon Pharmaceuticals AB Quarterly report: Q2 2025 - Filings